Skip to content
  • Sunday, 26 July 2026
  • 3:37 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Eli Lilly’s Retatrutide Shows Unprecedented Weight Loss, But Increased Side Effects Raise Tolerability Concerns
Laboratory Automation & Robotics

Eli Lilly’s Retatrutide Shows Unprecedented Weight Loss, But Increased Side Effects Raise Tolerability Concerns

Lana Keisha Jun 16, 2026 0

Eli Lilly and Company’s investigational drug, retatrutide, a pioneering triple hormone receptor agonist, has demonstrated an average weight loss of…

Read More
Molecular & Cell Biology

Antibiotic Residues Detected in Piracicaba River and Fish Raise Environmental and Public Health Concerns

Angie Faith Apr 5, 2026 0

Researchers from the Center for Nuclear Energy in Agriculture at the University of São Paulo (CENA-USP) have identified multiple classes…

Read More
Molecular & Cell Biology

Antibiotic Residues Found in Piracicaba River and Local Fish Raise Environmental and Public Health Alarms

Angie Faith Mar 29, 2026 0

Researchers from the Center for Nuclear Energy in Agriculture at the University of São Paulo (CENA-USP) have uncovered a disturbing…

Read More
Prenatal Estrogen Exposure and the Evolution of the Human Brain: Insights from Digit Ratio and Neonatal Head CircumferencePharma 2035 Playbook: Speed, focus and conviction in an uncertain worldRapid Evolution and Explosive Growth of Chronic Myeloid Leukemia Revealed by New Genomic StudyAMSBIO Biospecimens Fuel Landmark Roche Study Uncovering Fibroblast Activation Protein’s Critical Role in Cancer Immunotherapy
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ